World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria. - Test2 - elhamkhani - TriplyDB

World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.

World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.

http://www.wikidata.org/entity/Q30483555

about

Artemisinin-resistant malaria: research challenges, opportunities, and public health implications Monitoring of efficacy and safety of artemisinin-based anti-malarials for treatment of uncomplicated malaria: a review of evidence of implementation of anti-malarial therapeutic efficacy trials in Tanzania Advances in genetics and genomics: use and limitations in achieving malaria elimination goals Molecular evidence of increased resistance to anti-folate drugs in Plasmodium falciparum in North-East India: a signal for potential failure of artemisinin plus sulphadoxine-pyrimethamine combination therapy Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria Spatiotemporal mathematical modelling of mutations of the dhps gene in African Plasmodium falciparum.Molecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studies Molecular genomic approaches to infectious diseases in resource-limited settings Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy.Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance.Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.Molecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen: baseline data and implications Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations.Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in Uganda Host candidate gene polymorphisms and associated clearance of P. falciparum amodiaquine and fansidar resistance mutants in children less than 5 years in Cameroon.Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin Multinormal in vitro distribution model suitable for the distribution of Plasmodium falciparum chemosusceptibility to doxycycline.Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine.Assessment of molecular markers for anti-malarial drug resistance after the introduction and scale-up of malaria control interventions in western Kenya.A new high-throughput method for simultaneous detection of drug resistance associated mutations in Plasmodium vivax dhfr, dhps and mdr1 genes.Limited geographical origin and global spread of sulfadoxine-resistant dhps alleles in Plasmodium falciparum populations.Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.Differential association of Plasmodium falciparum Na+/H+ exchanger polymorphism and quinine responses in field- and culture-adapted isolates of Plasmodium falciparum.Development of a TaqMan Allelic Discrimination assay for detection of single nucleotides polymorphisms associated with anti-malarial drug resistance.Quinine-resistant malaria in traveler returning from Senegal, 2007 World Antimalarial Resistance Network (WARN) IV: clinical pharmacology.Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005 Single-nucleotide polymorphism and copy number variation of the multidrug resistance-1 locus of Plasmodium vivax: local and global patterns New insights into the Plasmodium vivax transcriptome using RNA-Seq.K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa.Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal.In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na+/H+ exchanger transporter (Pfnhe-1) gene in 393 isolates from Dakar, Senegal Mobile phones and malaria: modeling human and parasite travel.Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide-dependent.Nonradioactive heteroduplex tracking assay for the detection of minority-variant chloroquine-resistant Plasmodium falciparum in Madagascar A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria.Plasmodium falciparum Na+/H+ exchanger 1 transporter is involved in reduced susceptibility to quinine.Efficacy of sulphadoxine-pyrimethamine with or without artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in southern Mozambique: a randomized controlled trial Monitoring antifolate resistance in intermittent preventive therapy for malaria.The evolution of drug-resistant malaria.

P2860

Q21032532-634F0905-8563-4040-B6DC-CFEC3509633A Q26820807-263170F7-0F9F-4CA2-BD33-C2A9143BDC18 Q28082023-ADA6C2B0-AB4C-4C28-BA75-290BF4515B07 Q28125911-D70B9D4E-32BC-4C62-978B-4ABF21F0B5EB Q28475195-600525DD-5A3C-4877-BEEB-A0A917AE7BB2 Q30541962-383B54B8-4726-450A-BC2C-A50C3D403A9C Q30568502-B91DCE3B-3A75-4278-8711-0C1172A928C1 Q33512515-718D17A8-C091-4179-A226-090803006251 Q33576812-F8AE0234-FB55-43BB-8CD2-7938932C6E71 Q33645352-B768F432-BC6E-4418-8A2A-0C010556439F Q33778751-14CC2BED-9A1B-462C-8EBE-B0C310538452 Q33997904-F32DACD3-C9A3-4797-9629-5C61044F682B Q34134036-D93AEC6B-1C21-4888-BF0A-C0625A3D1CBC Q34529355-3D07D87C-F384-407B-951B-2758B63C6927 Q34562743-9409D4BB-14BF-4A81-BA9C-E6CE9293DB13 Q34597550-8D4A412E-EAC4-4078-8D2E-1DA7D1FFD0FE Q34601191-6319EB64-D275-41A0-B95D-004A3541DFB6 Q35068138-D86B0F57-69D1-4F19-9E1E-22798C63B36B Q35092092-C647E2D2-7731-4074-882E-BD70CDF3390E Q35338795-19B4F43E-F344-4362-88E2-1C1D3C95CB8D Q35532863-71CB4AB2-EF03-4ACA-B24D-AE16F485A537 Q35576130-D65DA90D-50DC-412A-91BB-2A884B46B924 Q35598582-42B6B024-8AB4-451C-853A-5DBA949F6D32 Q35739716-2B5FBF22-B3C4-4E31-BAD8-D4FA5A5E0D45 Q35877446-F6B327F6-0D97-4A74-90CE-6EDF2EA2C9CA Q36054710-D3DA4B9D-DF2C-49F9-8A32-35F9F877CF0B Q36161013-BEA18036-F3D2-4D8D-BBE7-3D2940BF483E Q36450610-F15DEABA-F242-47F2-9A41-A70588CEA87C Q36560001-180EA22A-CFE8-4FFE-9319-3AAE65B62E24 Q36786733-5AAF8018-FB65-4A19-BB2F-35E83FE80466 Q36840090-902FC971-02C7-4036-8F31-9321F1A6906C Q36921820-55A889EF-CCCC-456C-B095-70E35EE33C9A Q36969072-AC0068FF-8D84-4EA1-B0E4-F8389848235A Q37138144-0D4C98F4-D652-44D0-A329-140D166D3ABE Q37148927-3F80F48D-29CF-4A90-AA7E-3F4310970D19 Q37190605-3AC02BBB-341E-4BE1-A2E8-8C4DC739880B Q37190763-8B82B2BD-A54F-4204-9116-D4FAF100661D Q37257937-E06AF8B8-A863-42F0-8085-4D647E10A837 Q37260585-47C767FA-ABA7-466A-ADD0-3AC6BD892A42 Q37297141-6C83B4B7-DA1C-4419-B39C-3AA462B8A800

P2860

World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.

http://www.wikidata.org/entity/Q30483555

description

2007 nî lūn-bûn

@nan

2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

World Antimalarial Resistance ...... rs for drug resistant malaria.

@ast

World Antimalarial Resistance ...... rs for drug resistant malaria.

@en

type

label

World Antimalarial Resistance ...... rs for drug resistant malaria.

@ast

World Antimalarial Resistance ...... rs for drug resistant malaria.

@en

prefLabel

World Antimalarial Resistance ...... rs for drug resistant malaria.

@ast

World Antimalarial Resistance ...... rs for drug resistant malaria.

@en

P1433

Q30483555-F64865D3-387F-4905-AE53-09A2098F3886

P1476

Q30483555-3FDA5FF7-A731-40E9-91F3-428F21757BB2

P2093

Q30483555-029ED1EE-116F-4BC1-A717-2005A35385AF

Q30483555-28D83E1F-F59E-4AEE-98C0-453FE8AE1755

Q30483555-99ED718A-3D60-4999-8875-170BA303CBCA

Q30483555-A264A0FD-2438-47FD-826E-4DF5103F2539

Q30483555-A999FC5E-399E-42C1-9BD9-ED431D59257E

Q30483555-D19C550B-C9E6-4B88-ABE8-E6CC8F0C2C83

Q30483555-E88F3D7F-9C3A-4506-8085-6ED927516B77

P2860

Q30483555-01948369-BFAF-4C97-833C-937F2E6B3AA5

Q30483555-01ABFAE3-26EF-48D4-99C5-BA1ABB5997EF

Q30483555-0629DA35-92E0-4CF7-9E7D-2C44B4F0CB66

Q30483555-0A13C198-FF4C-40CF-8598-B7CCFE95DDE9

Q30483555-102B8616-9B3E-4A86-9ACF-6A2473232332

Q30483555-1BACC4E0-8BFE-4C9A-8B80-888856C04C7E

Q30483555-1C05F8F7-FD53-4862-B8B3-EC33EE9F9E79

Q30483555-1D2230D1-89BE-480A-B9E3-FE2BA75E2620

Q30483555-2103AD41-6B27-4D3D-B1D4-84B9A5DE3573

Q30483555-21651227-23CA-4D2F-AFBA-F7E6182FA887

P2888

Q30483555-91CF98E4-BB4A-46D7-A80B-3E81A9416FC0

P304

Q30483555-6DD46CB1-2680-4557-90EE-CE003AE9EE92

P31

Q30483555-C98DD424-0CEE-4BB4-BAF3-FE436E55CD97

P356

Q30483555-F985E5CC-09A1-4627-ACE3-C98CC2DE5F4D

P478

Q30483555-5C249DAA-4CE6-4DFF-945B-CBF13987B0AA

P50

Q30483555-2BBF8E10-1608-470F-A43C-BD8DE246868B

Q30483555-48E95EAF-5B8C-4414-BCF5-22993578879C

Q30483555-5CDC3532-0789-44E9-A6E9-AE8ED07B0DE3

Q30483555-96415F3C-CE96-4AF1-83D2-8ECA44390145

Q30483555-D7ADC39E-2FB9-4314-A850-728E08A6220A

Q30483555-D8799D8C-79CE-446B-BF7F-9E5536FE3CD5

Q30483555-DC93B7A8-8FE5-4225-85AF-5AC35967176B

Q30483555-DE21D357-00BC-4BDB-9FD9-DC411B548F44

P577

Q30483555-A304066F-358E-4B54-A812-23F98F724D02

P5875

Q30483555-729DDE93-D085-4F18-ACE3-ACAE4FB7F1DD

P6179

Q30483555-38A0EA5B-745D-4E2E-8081-9DFDABD65374

P698

Q30483555-D1E06DA9-A7BD-4562-8A70-424B616E8F0F

P921

Q30483555-24DCE6EB-3DF5-4EDB-BC8C-CD1731221656

Q30483555-6CCFD8C6-08ED-4F0C-BF5D-FE86BC3A9907

P932

Q30483555-D815A84C-5DCC-4761-9801-24A06194D595

P356

1475-2875-6-121

P1433

Malaria Journal

P1476

World Antimalarial Resistance ...... rs for drug resistant malaria.

@en

P2093

Carol H Sibley

http://www.w3.org/2001/XMLSchema#string

Hema H Joshi

http://www.w3.org/2001/XMLSchema#string

John W Barnwell

http://www.w3.org/2001/XMLSchema#string

Kefas Mugittu

http://www.w3.org/2001/XMLSchema#string

Peter A Zimmerman

http://www.w3.org/2001/XMLSchema#string

Ric N Price

http://www.w3.org/2001/XMLSchema#string

Robert W Shafer

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular surveillance of drug resistance through imported isolates of Plasmodium falciparum in Europe

Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum

Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria.

Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance

Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number

A molecular marker for chloroquine-resistant falciparum malaria.

Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance.

Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia.

A molecular surveillance system for global patterns of drug resistance in imported malaria

Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria

P2888

1475-2875-6-121

P304

121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2875-6-121

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Christopher V Plowe

Colin J Sutherland

Wilfred Fon Mbacham

Inbarani Naidoo

Philip J Rosenthal

Steven R Meshnick

Christian T. Happi

P577

2007-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6016987

http://www.w3.org/2001/XMLSchema#string

P6179

1015364901

http://www.w3.org/2001/XMLSchema#string

P698

17822535

http://www.w3.org/2001/XMLSchema#string

P921

P932

2008207

http://www.w3.org/2001/XMLSchema#string